STOCK TITAN

KindlyMD Secures $200 Million Credit Facility from Two Prime and Completes Convertible Note Redemption

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

KindlyMD (NASDAQ:NAKA) secured a $203,017,500 term loan facility from Two Prime Lending Limited to Naka SPV 2, LLC on October 3, 2025.

Proceeds were primarily used to redeem a $200 million convertible debenture held by YA II PN, Ltd., plus 1.5% interest; redemption notice was delivered September 15, 2025, and repayment completed September 30, 2025 (less conversions through September 29, 2025).

The financing aims to strengthen KindlyMD's balance sheet, align capital structure with shareholders, preserve Bitcoin holdings via Nakamoto Holdings, and support the company's long-term growth strategy following the August 2025 merger with Nakamoto.

KindlyMD (NASDAQ:NAKA) ha ottenuto una linea di credito a termine di $203,017,500 dalla Two Prime Lending Limited verso Naka SPV 2, LLC, il 3 ottobre 2025.

I proventi sono stati principalmente utilizzati per rimborsare un'obbligazione convertibile da $200 milioni, detenuta da YA II PN, Ltd., più interessi del 1,5%; è stata inviata una notifica di rimborso il 15 settembre 2025 e il pagamento è stato completato il 30 settembre 2025 (con conversioni fino al 29 settembre 2025).

Il finanziamento mira a rafforzare il bilancio di KindlyMD, allineare la struttura del capitale agli azionisti, preservare le consistenze di Bitcoin tramite Nakamoto Holdings e supportare la strategia di crescita a lungo termine dell'azienda a seguito della fusione di agosto 2025 con Nakamoto.

KindlyMD (NASDAQ:NAKA) obtuvo una línea de préstamo a plazo de $203,017,500 de Two Prime Lending Limited para Naka SPV 2, LLC el 3 de octubre de 2025.

Los ingresos se utilizaron principalmente para canjear una bono convertible de $200 millones, poseído por YA II PN, Ltd., más un interés del 1,5%; se entregó un aviso de redención el 15 de septiembre de 2025 y el pago se completó el 30 de septiembre de 2025 (con conversiones hasta el 29 de septiembre de 2025).

La financiación tiene como objetivo fortalecer el balance de KindlyMD, alinear la estructura de capital con los accionistas, preservar las tenencias de Bitcoin a través de Nakamoto Holdings y respaldar la estrategia de crecimiento a largo plazo de la empresa tras la fusión de agosto de 2025 con Nakamoto.

KindlyMD (NASDAQ:NAKA)가 2025년 10월 3일에 Naka SPV 2, LLC에 $203,017,500의 기간대출 facility를 Two Prime Lending Limited로부터 확보했습니다.

수익은 주로 YA II PN, Ltd.가 보유한 $200백만의 전환사채와 1.5%의 이자를 상환하는 데 사용되었으며; 상환 통지는 2025년 9월 15일에 전달되었고 2025년 9월 30일에 상환이 완료되었습니다(2025년 9월 29일자까지의 전환은 제외).

이번 자금조달은 KindlyMD의 재무상태를 강화하고, 주주들과의 자본구조를 일치시키며 Nakamoto Holdings를 통해 비트코인 보유를 보존하고, 2025년 8월 Nakamoto와의 합병 이후의 장기 성장 전략을 지원하는 것을 목표로 합니다.

KindlyMD (NASDAQ:NAKA) a obtenu une ligne de prêt à terme de $203 017 500 auprès de Two Prime Lending Limited pour Naka SPV 2, LLC le 3 octobre 2025.

Les produits ont été principalement utilisés pour racheter une obligation convertible de $200 millions, détenue par YA II PN, Ltd., plus un intérêt de 1,5%; l'avis de rachat a été envoyé le 15 septembre 2025 et le remboursement a été achevé le 30 septembre 2025 (avec les conversions jusqu'au 29 septembre 2025).

Le financement vise à renforcer le bilan de KindlyMD, aligner la structure du capital avec les actionnaires, préserver les avoirs en Bitcoin via Nakamoto Holdings et soutenir la stratégie de croissance à long terme de l'entreprise suite à la fusion d'août 2025 avec Nakamoto.

KindlyMD (NASDAQ:NAKA) sicherte sich am 3. Oktober 2025 eine Tilgungsvorgang Kreditlinie von $203,017,500 von Two Prime Lending Limited an Naka SPV 2, LLC.

Die Erlöse wurden hauptsächlich verwendet, um eine $200 Millionen -Wandelschuldverschreibung, gehalten von YA II PN, Ltd., plus 1,5% Zinsen zurückzuzahlen; Rückrufmitteilung wurde am 15. September 2025 zugestellt, und die Rückzahlung wurde am 30. September 2025 abgeschlossen (Conversions bis zum 29. September 2025 ausgeschlossen).

Die Finanzierung zielt darauf ab, die Bilanz von KindlyMD zu stärken, die Kapitalstruktur mit den Aktionären auszurichten, Bitcoin-Bestände über Nakamoto Holdings zu bewahren und die langfristige Wachstumsstrategie des Unternehmens nach der Fusion mit Nakamoto im August 2025 zu unterstützen.

KindlyMD (NASDAQ:NAKA) قد أمنت تسهيل قرض كبير لمدة $203,017,500 من Two Prime Lending Limited إلى Naka SPV 2, LLC في 3 أكتوبر 2025.

تم استخدام العائدات بشكل رئيسي لسداد $200 مليون من سندات قابلة للتحويل مملوكة لـ YA II PN, Ltd., بالإضافة إلى فائدة 1.5%; تم إرسال إشعار الإطفاء في 15 سبتمبر 2025، وتم إكمال السداد في 30 سبتمبر 2025 (باستثناء التحويلات حتى 29 سبتمبر 2025).

يهدف التمويل إلى تعزيز ميزانية KindlyMD، وتوافق هيكل رأس المال مع المساهمين، والحفاظ على ممتلكات Bitcoin عبر Nakamoto Holdings، ودعم استراتيجية النمو طويلة الأجل للشركة عقب الدمج مع Nakamoto في أغسطس 2025.

KindlyMD (NASDAQ:NAKA)$203,017,500 的期限贷款由 Two Prime Lending Limited 提供给 Naka SPV 2, LLC,日期为 2025 年 10 月 3 日。

资金主要用于偿还由 YA II PN, Ltd. 持有的 $200 百万美元 的可转换债券,以及 1.5% 的利息;赎回通知在 2025 年 9 月 15 日递交,偿还在 2025 年 9 月 30 日完成(截至 2025 年 9 月 29 日的转换除外)。

本轮融资旨在加强 KindlyMD 的资产负债表,使资本结构与股东保持一致,通过 Nakamoto Holdings 保护比特币持有,并支持公司在 2025 年 8 月与 Nakamoto 合并后的长期增长战略。

Positive
  • Term loan of $203,017,500 from Two Prime
  • Convertible debenture redemption of $200,000,000
  • Redemption completed on September 30, 2025
  • Merger with Nakamoto completed August 2025
Negative
  • Redeemed convertible removed potential conversion at $2.80/share
  • Interest cost on redeemed debenture of 1.5%

Insights

KindlyMD secured a $203,017,500 term loan and redeemed a $200 million convertible debenture, strengthening liquidity and reducing dilution.

The company obtained a term loan of $203,017,500 from Two Prime, with proceeds used primarily to redeem a $200 million convertible debenture held by YA II PN, Ltd.

What it means: the redemption eliminates a convertible instrument with a $2.80 conversion price and 1.5% interest, removing a potential source of share dilution tied to that debenture and simplifying the capital structure. Why it matters: the new facility provides immediate liquidity and lets the company preserve its disclosed Bitcoin holdings while positioning the balance sheet for longer‑term initiatives.

Monitorable item: the press release states the redemption amount was fully repaid on September 30, 2025.

Provides Flexibility to Pursue Long-Term Growth Strategy While Preserving Bitcoin Holdings and Strengthening the Company's Balance Sheet

SALT LAKE CITY, UT, UT / ACCESS Newswire / October 3, 2025 / KindlyMD, Inc. (NASDAQ:NAKA) ("KindlyMD" or "the Company"), a provider of integrated healthcare services and a Bitcoin treasury vehicle via its subsidiary Nakamoto Holdings ("Nakamoto"), today announced that it has entered into an open credit facility with Two Prime Lending Limited ("Two Prime"), the secured lending affiliate of Two Prime Inc., pursuant to which Naka SPV 2, LLC ("Naka 2") received a term loan from Two Prime in the principal amount of $203,017,500.

Proceeds from the financing were primarily used for the redemption of a $200 million convertible debenture, plus 1.5% interest, with YA II PN, Ltd., an investment fund managed by Yorkville Advisors ("Yorkville"), which had a conversion price of $2.80 per share.

"We are pleased to work with Two Prime, a leading Bitcoin-native lender that is aligned with our vision and treasury strategy," said Tyler Evans, Chief Investment Officer of KindlyMD. "This financing, together with the redemption of the convertible note, is an important step we are taking to enhance KindlyMD's balance sheet, align our capital structure with shareholders, and position the company to advance from a position of strength."

The Notice of Redemption for the Convertible Debenture was delivered Monday, September 15, 2025, and the redemption amount, less any amounts converted on or prior to September 29, 2025, was fully repaid on September 30, 2025.

‍About KindlyMD
KindlyMD® is a patient-first and healthcare data company redefining value-based care and patient-centered medical services. Formed in 2019, KindlyMD leverages data analysis to deliver evidence-based, personalized solutions in order to reduce opioid use, improve health outcomes faster, and provide value based, algorithmic guidance on the use of alternative medicine in healthcare. In August 2025, KindlyMD completed its merger with Nakamoto Holdings Inc., a Bitcoin-native holding company. This strategic partnership formed a public Bitcoin treasury strategy that unites KindlyMD's healthcare expertise with Nakamoto's vision of integrating Bitcoin into global capital markets, creating a diversified entity focused on both healthcare innovation and Bitcoin treasury management.

About Two Prime Lending
Two Prime Lending Limited delivers secured credit solutions to institutional bitcoin holders, offering over $3 billion in lending capacity. The firm provides flexible, non-rehypothecated loans backed by collateral held in segregated, secured custody, a model built to protect client assets and promote long-term trust in digital finance. Borrowers include miners, asset managers, family offices, and corporate treasuries seeking capital-efficient access to liquidity without compromising security. We are an affiliate of Two Prime Inc., an SEC-Registered Investment Advisor specializing in digital asset quantitative trading, risk management, and trading for institutional clients.

Forward-Looking Statements
All statements, other than statements of historical fact, included in this press release that address activities, events or developments that that the Company expects, believes or anticipates will or may occur in the future are forward-looking statements, as defined under U.S. federal securities laws, related to the Company. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and often include statements about our future operations, business strategies, plans, objectives, expectations, intentions, goals, projections, prospects, future events, or performance, as well as underlying assumptions. These statements-covering matters such as expectations, plans, strategic outlooks, financial projections, market conditions, regulatory environments, Bitcoin-related strategies, Bitcoin treasury management activities, and the Company's anticipated holding of Bitcoin as part of its corporate treasury are inherently uncertain and involve numerous assumptions and risks.

Forward-looking terms used may include, but are not limited to, "estimate," "project," "predict," "believe," "expect," "anticipate," "potential," "create," "intend," "could," "would," "may," "plan," "will," "guidance," "look," "goal," "future," "build," "focus," "continue," "strive," "allow," "seek," "aim," "target," or the negative of such terms or other variations thereof and words and terms of similar substance used in connection with any discussion of future plans, actions, or events identify forward-looking statements and similar expressions. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements include, but are not limited to, descriptions of the Company and its operations, strategies and plans, integration, debt levels and leverage ratio, capital expenditures, cash flows and anticipated uses thereof, including the purchase, custody, and potential sale or other use of Bitcoin, synergies, opportunities and anticipated future performance, including the management team and board of directors of the Company. These statements may also relate to broader macroeconomic trends, industry developments, technology adoption, competitive positioning, market expansion, product launches, research and development efforts, acquisitions or dispositions, legal or regulatory developments, and other initiatives that could affect our future business performance. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this communication. These include risks relating to Bitcoin market volatility, cybersecurity and custody of digital assets, potential changes in laws or accounting standards relating to cryptocurrency, and regulatory developments affecting Bitcoin or other digital assets, as well as the risk that changes in the Company's capital structure and governance could have adverse effects on the market value of its securities; the ability of the Company to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on the Company operating results and business generally; the risk that the Company may be unable to reduce expenses or access financing or liquidity; the impact of any related economic downturn; the risk of changes in governmental regulations or enforcement practices; adverse impacts from geopolitical events, health crises, supply chain disruptions, changes to laws or accounting standards, cybersecurity threats or data breaches, intellectual property disputes, competitive pressures, or changes in consumer behavior; and other important factors that could cause actual results to differ materially from those projected. All such factors are difficult to predict and are beyond the Company's control, including those detailed in the Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10- Q, Current Reports on Form 8-K, and such other documents of the Company filed, or to be filed, with the SEC that are or will be available on the Company's website at www.kindlymd.com and on the website of the SEC at www.sec.gov. All forward-looking statements are based on assumptions that the Company believes to be reasonable but that may not prove to be accurate. Any forward-looking statement speaks only as of the date on which such statement is made, and the Company does not undertake any obligation to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Nothing contained herein constitutes an offer to buy or sell securities of the Company or any other party, nor does it constitute a solicitation of any proxy or vote.

Investor Relations Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
KindlyMD@KCSA.com

KindlyMD Media Contact:
Carissa Felger / Sam Cohen
Gasthalter & Co.
(212) 257-4170
Nakamoto@gasthalter.com

Two Prime Media Contact:
Dukas Linden Public Relations
twoprime@dlpr.com

SOURCE: KindlyMD, Inc



View the original press release on ACCESS Newswire

FAQ

What financing did KindlyMD (NAKA) announce on October 3, 2025?

KindlyMD announced a $203,017,500 term loan facility from Two Prime.

How much of KindlyMD's financing was used to redeem the convertible note?

$200 million of the proceeds were used to redeem the convertible debenture.

When was the convertible debenture redemption for NAKA completed?

The redemption amount was fully repaid on September 30, 2025, after a September 15 notice.

Who held the redeemed convertible debenture for KindlyMD (NAKA)?

YA II PN, Ltd., an investment fund managed by Yorkville Advisors, held the debenture.

What was the conversion price on KindlyMD's redeemed convertible debenture?

The debenture had a conversion price of $2.80 per share.

How does the Two Prime loan affect KindlyMD's Bitcoin treasury strategy?

Management states the loan provides flexibility to pursue growth while preserving Bitcoin holdings via Nakamoto.
Kindly Md, Inc.

NASDAQ:NAKA

NAKA Rankings

NAKA Latest News

NAKA Latest SEC Filings

NAKA Stock Data

454.96M
347.02M
5.96%
0.22%
0.39%
Medical Care Facilities
Services-health Services
Link
United States
SALT LAKE CITY